Serclutamab talirine

Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.

CAS No. 2140174-56-5

サイズ	価格(税別)	在庫状況
1mg	JPY 145500	国内在庫あり
1mg*5	JPY 445500	お問い合わせ

代表番号: 045-509-1970\|電子メール：[email protected] よく尋ねられる質問

質量管理及び製品安全説明書

現在のバッチを見る： D402701 純度： 96.45% タンパク質濃度： 4.06mg/ml 内毒素：＜1EU/mg

96.45

EGFR阻害剤の選択性比較

生物活性

製品説明	Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.

製品説明

Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.

参考
[1] Carneiro BA, et al. Journal of Clinical Oncology 38, no. 15_suppl

参考

[1] Carneiro BA, et al. Journal of Clinical Oncology 38, no. 15_suppl

製品説明

CAS No.	2140174-56-5
Formulation	1xPBS
ADC antiody	Serclutamab
ADC cytotoxin	PBD
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping	Shipped under low temperature conditions

質量管理及び製品安全説明書

EGFR阻害剤の選択性比較

生物活性

製品説明

技術サポート